Alkermes PLC. (ALKS) — 10-Q Filings

10-Q Filings (6)

• Alkermes Q3 Net Income Dips Amid Rising Product Sales, R&D Spend — Oct 28, 2025 Risk: medium
  Alkermes plc reported a mixed financial performance for the three and nine months ended September 30, 2025. Total revenues for the three months increased to $39
• Alkermes Q2 Soars on LYBALVI, Net Income Jumps 25% — Jul 29, 2025 Risk: medium
  Alkermes plc. reported a robust financial performance for Q2 2025, with total revenues reaching $400.0 million, a significant increase from $370.0 million in Q2
• Alkermes Q1 2025 10-Q Filed — May 1, 2025 Risk: medium
  Alkermes plc. filed a 10-Q for the period ending March 31, 2025. The filing details financial performance, including revenue from key products like Vumerity and
• Alkermes plc. Files Q3 2024 10-Q — Oct 24, 2024 Risk: medium
  Alkermes plc. filed a 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter. Spe
• Alkermes plc. Files Q2 2024 10-Q — Jul 24, 2024 Risk: low
  Alkermes plc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter. Key f
• Alkermes plc. Files 10-Q for Period Ending March 31, 2024 — May 1, 2024 Risk: medium
  Alkermes plc. (ALKS) filed a Quarterly Report (10-Q) with the SEC on May 1, 2024. Alkermes plc. filed a 10-Q report for the period ending March 31, 2024. The fi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX